# Red Cell Lysis Buffer Application Versus Conventional Sample Processing in EUS-FNB

> **NCT05954221** · NA · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 66 (estimated)

## Conditions studied

- Pancreatic Diseases

## Interventions

- **PROCEDURE:** Red cell lysis buffer (RCLB) application
- **PROCEDURE:** Conventional processing

## Key facts

- **NCT ID:** NCT05954221
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-15
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05954221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05954221, "Red Cell Lysis Buffer Application Versus Conventional Sample Processing in EUS-FNB". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05954221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*